Mendelia

Name: Mendelia
Brand: Mendelia

AI Native

Mendelia is an automated healthcare agent that automates insurance administration workflows—including eligibility checks, prior authorization submission and status tracking, and identification of patient assistance programs—while integrating with EHR systems and payer portals.

Est 2025|Raised $500K

LinkedIn 67|Website|FTEs 2|HQ New York, New York, US

MarketsInteractive Voice Response (IVR)

Published Oct 8, 2026

01Common complaints

- Scenarios where alternatives are likely better - If a mature, publicly documented security posture is required - The vendor’s public site does not specify SOC 2 type, audit scope, auditor, or report access path. Some competitors publicly disclose SOC 2 Type II reports and BAA coverage, which can accelerate security reviews. - If strong, verifiable evidence of outcomes is required (public case studies, named references, independent reviews) - The vendor has limited public proof points; consider a vendor with named references and third-party reviews. - If the requirement is broad operations automation beyond prior authorization and eligibility - A broader platform that covers multiple operational areas may be a better fit if prior authorization is one of many priorities. - If a single-portal workflow replacement is desired rather than an agent-style automation approach - Some vendors offer single-portal workflow replacements and may suit teams that prioritize standardization and centralized reporting. - Budget constraints - Because vendor pricing is not public, budget fit is uncertain; buyers with strict budgets may prefer vendors that publish pricing or pricing drivers. - Current limitations acknowledged by the vendor - The vendor does not publicly enumerate limitations on its site. - Features on the roadmap (not yet available) - Not publicly documented. - Scale limitations - Not publicly documented. - Security or compliance gaps - The vendor asserts HIPAA and SOC 2 compliance at a high level but has not published SOC 2 type, audit scope, or report access details. For many enterprise buyers, a SOC 2 Type II report under NDA and a signed BAA are minimum procurement requirements. - API limitations or integration constraints - Not publicly documented.

Deal disqualifiers: what makes a poor fit

Very low prior authorization volume (weak automation ROI)
Organizations requiring documented SOC 2 Type II reports or extensive public security detail before engagement
Highly fragmented multi-EHR environments without a centralized intake process

02Why they buy

- Competitive advantages validated by customer feedback (not just vendor claims) - Not available due to lack of public review coverage. - Unique features and capabilities competitors may not prioritize - The vendor explicitly includes patient assistance program identification in its automation messaging, which some prior-authorization-focused vendors do not emphasize. - Differentiation from competitors based on reviews - Not possible to assess due to lack of vendor-specific review coverage. - Areas where competitors clearly have advantages - Compliance transparency: some competitors publish SOC 2 Type II details and BAA coverage publicly, which reduces procurement friction. - Broader automation and modality coverage: some competitors describe portal navigation, browser automation, and calling capabilities in more detail and provide clearer deployment timelines.

03Field reports

Customer Testimonials

- Availability of reviews on major platforms - No accessible Gartner Peer Insights listing for the vendor was identified in available searches. - No vendor product listing was found on G2 in accessible search results. - No product page was found on TrustRadius in accessible search results. - Overall: review-platform coverage appears minimal or non-existent publicly, consistent with an early-stage vendor. - Community and social proof - Direct, vendor-specific user quotes were not located on Reddit, Hacker News, or other forums during this research. - What is available are general community discussions about prior authorization pain points and buyer expectations for PA automation tools. - Representative community quotes (context for the market problem) - On portal and phone friction: users report frequent difficulty with payer phone systems and portal failures. - On payer-side opacity: users report that some plans do not make clinical criteria readily available even when portal access exists. - On multi-site operations requirements: some operators recommend prioritizing normalization of intake and reporting across multiple EHRs to consolidate backlogs. - Balance note - Because the vendor has little or no public review footprint, this section documents vendor claims, broader market complaints, and competitor review indicators where available rather than a set of vendor-specific star ratings.

Vendor-published case studies

No public case studies were located on the vendor site or in accessible sources.

Critical evaluation

Without public case studies, the vendor’s claimed benefits (time saved, reduced denials, faster approvals) are not independently verifiable. Buyers should request:
- Baseline and post-implementation KPIs (turnaround time, denial rates, staff minutes per prior authorization)
- Methodology for KPI calculation
- Breakdown by payer and specialty, since results commonly vary by these factors

04Best fit

Company sizes: specific employee counts and revenue ranges

- Best-guess ICP (based on problem addressed and early-stage vendor status): - Specialty practices, ambulatory groups, and MSOs - Practices or organizations of small-to-mid size where prior authorization volume is sufficient for automation ROI but procurement overhead is lighter than that of large integrated delivery networks - Very large health systems typically require deep integration, extensive security documentation, and additional certifications.

Industries and verticals where adoption is strongest

Specialties with high prior authorization volumes and higher denial risk, such as cardiology imaging, orthopedics, rheumatology (biologics), oncology supportive therapies, and endocrinology for GLP-1 therapies

Roles and personas: decision makers and end users

Decision makers: practice administrators, revenue cycle leadership, clinical operations
End users: prior authorization coordinators, medical assistants, front desk and referral coordinators

Pain points and challenges the product addresses

Payer phone trees, duplicated portal entry, repetitive data entry, policy volatility, missed assistance programs, and delayed care

Qualification criteria: what makes a good fit

High prior authorization volume with consistent documentation practices
An EHR that supports integration or data export
Willingness to run a pilot with measurable baseline KPIs
Clear internal ownership of exception handling

05The pitch

What the product does (core value proposition in objective terms)

- Mendelia describes its product as an automated agent for healthcare that focuses on automating insurance administration workflows for provider organizations. - Core workflows explicitly mentioned by the vendor include: - Eligibility checks - Prior authorization submission and status tracking - Surfacing patient assistance programs - Extracting authorization requirements and coverage details from payer portals - EHR connectivity (vendor indicates integration with EHR systems and payer portals)

Target market and market positioning

Target customers appear to be specialty practices and other provider groups that manage benefits verification (VoB), prior authorization, and payer follow-up.
Positioning centers on automating repetitive administrative tasks to reduce delays in care and denials, according to vendor statements.

Get a comprehensive analysis of Mendelia including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →